Potency Meets Precision in Nano-optimized Chemotherapeutics

Artavazd Arumov; Asaad Trabolsi; Jonathan H. Schatz

doi:10.1016/j.tibtech.2021.03.004

Potency Meets Precision in Nano-optimized Chemotherapeutics

Artavazd Arumov, Asaad Trabolsi, Jonathan H. Schatz

Medicine

Research output: Contribution to journal › Short survey › peer-review

9 Scopus citations

Abstract

Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.

Original language	English (US)
Pages (from-to)	974-977
Number of pages	4
Journal	Trends in Biotechnology
Volume	39
Issue number	10
DOIs	https://doi.org/10.1016/j.tibtech.2021.03.004
State	Published - Oct 2021

Keywords

cancer
drug delivery
lymphoma
nanotechnology
precision medicine
therapeutics

ASJC Scopus subject areas

Biotechnology
Bioengineering

Access to Document

10.1016/j.tibtech.2021.03.004

Cite this

@article{88ab3ef300c442849469053a4f4ca2a4,

title = "Potency Meets Precision in Nano-optimized Chemotherapeutics",

abstract = "Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.",

keywords = "cancer, drug delivery, lymphoma, nanotechnology, precision medicine, therapeutics",

author = "Artavazd Arumov and Asaad Trabolsi and Schatz, {Jonathan H.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",

year = "2021",

month = oct,

doi = "10.1016/j.tibtech.2021.03.004",

language = "English (US)",

volume = "39",

pages = "974--977",

journal = "Trends in Biotechnology",

issn = "0167-7799",

publisher = "Elsevier Ltd",

number = "10",

}

TY - JOUR

T1 - Potency Meets Precision in Nano-optimized Chemotherapeutics

AU - Arumov, Artavazd

AU - Trabolsi, Asaad

AU - Schatz, Jonathan H.

PY - 2021/10

Y1 - 2021/10

N2 - Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.

AB - Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.

KW - cancer

KW - drug delivery

KW - lymphoma

KW - nanotechnology

KW - precision medicine

KW - therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85103710079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103710079&partnerID=8YFLogxK

U2 - 10.1016/j.tibtech.2021.03.004

DO - 10.1016/j.tibtech.2021.03.004

M3 - Short survey

C2 - 33832781

AN - SCOPUS:85103710079

SN - 0167-7799

VL - 39

SP - 974

EP - 977

JO - Trends in Biotechnology

JF - Trends in Biotechnology

IS - 10

ER -

Potency Meets Precision in Nano-optimized Chemotherapeutics

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this